Read + Share
Kvistad SAS, Burman J, Lehmann AK, Tolf A, et al. Impact of previous disease-modifying treatment on safety and efficacy in patients
with MS treated with AHSCT. J Neurol Neurosurg Psychiatry 2022;93:844-848.
PMID: 35508373
|
 |
|
Kvistad SAS, Burman J, Lehmann AK, Tolf A, et al. Impact of previous disease-modifying treatment on safety and efficacy in patients
with MS treated with AHSCT. J Neurol Neurosurg Psychiatry 2022;93:844-848.
PMID: 35508373
|
|
|
|